PITTSBURGH, Nov 12, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan SA has received the prestigious 2009 Elsevier Galien Award for Best Generics Company in Spain. The award recognizes the company's outstanding development in the country during the last year and its introduction of new, high quality generic medicines that generate savings for the national health care system. In addition, Mylan Inc.'s efforts in fighting HIV/AIDS in the developing world and the development of a generic biologics strategy contributed to the decision to grant Mylan SA this honor.

The prize is awarded by Elsevier, a leading international science and health care media company, and is granted annually to a public or private institution that shows an outstanding commitment to improving and promoting public health.

Mylan SA ranks third in Spain's generics market with nearly 200 products. Based in Barcelona, the company also runs a logistics centre in Llica d'Amunt, from where it offers superior service to pharmacies, distributors and hospitals across the country.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates the world's third largest active pharmaceutical ingredient manufacturer; and runs a specialty business focused on respiratory and allergy therapies. For more information, please visit www.mylan.com.

SOURCE Mylan Inc.

http://www.mylan.com

Copyright (C) 2009 PR Newswire. All rights reserved